Ketek and Hepatic function abnormal - a phase IV clinical study of FDA data

Summary:

Hepatic function abnormal is reported as a side effect among people who take Ketek (telithromycin), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Xanax, and have Sinusitis.

The phase IV clinical study analyzes which people have Hepatic function abnormal when taking Ketek. It is created by eHealthMe based on reports of 4,619 people who have side effects when taking Ketek from the FDA, and is updated regularly.

What is Ketek?

Ketek has active ingredients of telithromycin. eHealthMe is studying from 4,631 Ketek users. Check the latest studies of Ketek.

What is Hepatic function abnormal?

Hepatic function abnormal is found to be associated with 1,439 drugs and 2,020 conditions by eHealthMe. Check the latest studies of Hepatic function abnormal.

On Jul, 11, 2026

4,619 people reported to have side effects when taking Ketek.
Among them, 37 people (0.8%) have Hepatic function abnormal.

Could Ketek cause Hepatic function abnormal?

Among these 37 people:

How long have people been on Ketek when they have Hepatic function abnormal? *

What is the gender of people who have Hepatic function abnormal when taking Ketek? *

female: 27.03 %
male: 72.97 %

What is the age of people who have Hepatic function abnormal when taking Ketek? *

What are other drugs people take besides Ketek? *

Xanax: 10 people, 27.03%
Tylenol: 8 people, 21.62%
Zyrtec: 7 people, 18.92%
Phenazopyridine Hcl Tab: 7 people, 18.92%
Clarithromycin: 7 people, 18.92%
Decadron: 7 people, 18.92%
Diazepam: 7 people, 18.92%
Dilaudid: 7 people, 18.92%
Anzemet: 7 people, 18.92%
Ambien: 7 people, 18.92%

What are other side effects people have besides Hepatic function abnormal? *

Gamma-Glutamyltransferase Increased: 13 people, 35.14%
Aspartate Aminotransferase Increased: 13 people, 35.14%
Alanine Aminotransferase Increased: 12 people, 32.43%
Blood Bilirubin Increased: 10 people, 27.03%
Diarrhea: 9 people, 24.32%
Blood Alkaline Phosphatase Increased: 9 people, 24.32%
Itching: 9 people, 24.32%
Jaundice - Yellow Skin (a yellowish pigmentation of the skin): 7 people, 18.92%
Splenomegaly (enlargement of spleen): 7 people, 18.92%
Hepatic Steatosis (fatty liver disease): 7 people, 18.92%

What are the existing conditions these people have? *

Sinusitis (inflammation of sinus): 9 people, 24.32%
Tonsillitis (inflammation of tonsil): 6 people, 16.22%
Cough: 6 people, 16.22%
Pneumonia: 5 people, 13.51%
Respiratory Tract Infection: 4 people, 10.81%
Bronchitis Acute (acute inflammation of the mucous membrane in the bronchial tubes): 4 people, 10.81%
Stable Angina (a constant chest pain): 2 people, 5.41%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 2 people, 5.41%
Osteoporosis (bones weak and more likely to break): 2 people, 5.41%
Upper Respiratory Tract Inflammation: 1 person, 2.70%

* Approximation only. Some reports may have incomplete information.

Do you take Ketek and have Hepatic function abnormal?

- Check whether Hepatic function abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ketek:

Ketek (4,631 reports)

Browse all side effects of Ketek:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatic function abnormal:

Hepatic function abnormal (1,439 drugs)

Browse all the conditions that are associated with Hepatic function abnormal:

Hepatic function abnormal (2,020 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on telithromycin (the active ingredients of Ketek) and Ketek (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.